Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Pharmacology

• Publication date

  2006-10-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPHAR.2006.07.037PMID 16930590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological and Behavioral Characteristics of Interactions between Vigabatrin and Conventional Antiepileptic Drugs in Pentylenetetrazole-Induced Seizures in Mice: An Isobolographic Analysis

  2005cited by this paper
• Evidence for novel cannabinoid receptors.

  2005cited by this paper
• Isobolographic and Subthreshold Analysis of Interactions among Felbamate and Four Conventional Antiepileptic Drugs in Pentylenetetrazole‐induced Seizures in Mice

  2004cited by this paper
• Selective Antiepileptic Effects of N‐Palmitoylethanolamide, a Putative Endocannabinoid

  2004cited by this paper
• The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.

  2004cited by this paper
• Marijuana use and epilepsy

  2004cited by this paper
• Three-dimensional isobolographic analysis of interactions between lamotrigine and clonazepam in maximal electroshock-induced seizures in mice

  2004cited by this paper
• Cannabinoid physiology and pharmacology: 30 years of progress.

  2004cited by this paper
• Endocannabinoids and Their Implications for Epilepsy

  2004cited by this paper
• Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.

  2003cited by this paper
• Interactions Between Oxcarbazepine and Conventional Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis

  2003cited by this paper
• The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy

  2003cited by this paper
• Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics--a comparative study.

  2003cited by this paper
• Tiagabine Synergistically Interacts with Gabapentin in the Electroconvulsive Threshold Test in Mice

  2003cited by this paper
• Role of endogenous cannabinoids in synaptic signaling.

  2003cited by this paper
• Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.

  2002cited by this paper
• The interaction index: a measure of drug synergism

  2002cited by this paper
• Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo

  2001cited by this paper
• Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

  2001cited by this paper
• Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity.

  2001cited by this paper
• Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission

  2001cited by this paper
• Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study

  2001cited by this paper
• Anticonvulsant Activity of N‐Palmitoylethanolamide, a Putative Endocannabinoid, in Mice

  2001cited by this paper
• Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed

  2000cited by this paper
• Early identification of refractory epilepsy.

  2000cited by this paper
• Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices

  2000cited by this paper
• Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons

  1999cited by this paper
• Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).

  1999cited by this paper
• Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

  1998cited by this paper
• Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.

  1998cited by this paper
• Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

  1998cited by this paper
• Molecular characterization of human and mouse fatty acid amide hydrolases.

  1997cited by this paper
• The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.

  1997cited by this paper
• Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures

  1996cited by this paper
• Activation of the cannabinoid receptor by Δ9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus

  1996cited by this paper
• Cannabis: pharmacology and toxicology in animals and humans.

  1996cited by this paper
• The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.

  1996cited by this paper
• Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

  1996cited by this paper
• Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor

  1995cited by this paper
• Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.

  1995cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Cannabinoids modulate potassium current in cultured hippocampal neurons.

  1993cited by this paper
• Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.

  1993cited by this paper
• Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.

  1992cited by this paper
• Cannabinoid Receptor‐Regulated Cyclic AMP Accumulation in the Rat Striatum

  1991cited by this paper
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices.

  1991cited by this paper
• The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models.

  1991cited by this paper
• Illicit drug use and the risk of new-onset seizures.

  1990cited by this paper
• Primer of Applied Regression & Analysis of Variance

  1990cited by this paper
• What is synergy?

  1989cited by this paper
• Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.

  1989cited by this paper
• Combination of valproate and ethosuximide: antiepileptic and neurotoxic interaction.

  1988cited by this paper
• Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks

  1986cited by this paper
• Antiepileptic drug combinations and experimental background: The case of phenobarbital and phenytoin

  1986cited by this paper
• Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.

  1982cited by this paper
• Antiepileptic Potential of Cannabidiol Analogs

  1981cited by this paper
• Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

  1980cited by this paper
• Trimethoprim and rifampicin: in vitro activities separately and in combination.

  1975cited by this paper
• Anticonvulsant nature of marihuana smoking.

  1975cited by this paper
• Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids.

  1974cited by this paper
• Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids

  1974cited by this paper
• Anticonvulsant activity of ?8- and ?9-tetrahydrocannabinol in rats?

  1974cited by this paper
• Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats.

  1974cited by this paper
• The anticonvulsant activity of cannabidiol and cannabinol.

  1973cited by this paper
• Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminée

  1960cited by this paper
• The problem of synergism and antagonism of combined drugs.

  1953cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ‐ and MES‐Induced Seizures in Mice via 5‐HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways

  2025cites this paper
• N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease

  2023cites this paper
• Cannabinoid treatments in epilepsy and seizure disorders.

  2023cites this paper
• Regulatory Basis of Adipokines Leptin and Adiponectin in Epilepsy: from Signaling Pathways to Glucose Metabolism

  2023cites this paper
• ANTICONVULSANT EFFECT OFBERBERIS ARISTATA ROOT EXTRACT IN MICE

  2023cites this paper
• Hippocampal Cannabinoid 1 Receptors Are Modulated Following Cocaine Self-administration in Male Rats

  2022cites this paper
• C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Model

  2021cites this paper
• The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models

  2021cites this paper
• Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice

  2021cites this paper
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

  2020cites this paper
• Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice

  2020cites this paper
• The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.

  2020cites this paper
• Divergent Effects of Systemic and Intracollicular CB Receptor Activation Against Forebrain and Hindbrain-Evoked Seizures in Rats

  2020cites this paper
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology

  2019cites this paper
• Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain.

  2019cites this paper
• Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice

  2019cites this paper
• Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain.

  2019cites this paper
• Cannabidiol improves survivability, seizures and associated behavioural comorbidities in a range of animal models of epilepsy

  2019cites this paper
• Drug-drug interactions between antiepileptics and cannabinoids

  2019cites this paper
• Role of the endocannabinoid system in neurological disorders

  2019cites this paper
• Combination of phenobarbital with phenytoin and pregabalin produces synergy in the mouse tonic-clonic seizure model: An isobolographic analysis.

  2018cites this paper
• The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice

  2017cites this paper
• Anticonvulsant Effects of Aerial Parts of Verbena officinalis Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors

  2017cites this paper
• Influence of Ivabradine on the Anticonvulsant Action of Four Classical Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice

  2017cites this paper
• A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy

  2017cites this paper
• Effects of arachidonyl-2’-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice

  2017cites this paper
• Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

  2017cites this paper
• Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

  2016cites this paper
• Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  2016cites this paper
• Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction

  2016cites this paper
• Plant-Derived and Endogenous Cannabinoids in Epilepsy

  2016cites this paper
• Cannabinoids and Epilepsy

  2015cites this paper
• ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs.

  2015cites this paper
• Influence of arachidonyl‐2′‐chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side‐effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock‐induced seizure model and chimney test in mice

  2015cites this paper
• Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.

  2015cites this paper
• Cisplatin and etoposide combined therapy changes heat shock proteins ( HSPs ) expression in tumor cells

  2015cites this paper
• ANTI-CONVULSANT PROPERTY OF SYNTHESIZED COMPOUND DIHYDROPYRIMIDINONE-5 IN LABORATORY ANIMALS

  2015cites this paper
• Endocannabinoids and epilepsy

  2015influential citation
• The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats.

  2014cites this paper
• Future prospects for cannabinoids and endogenous cannabinoid system in the epileptic brain - A short overview of the latest scientific reports

  2014cites this paper
• Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice.

  2013cites this paper
• Evaluation of anticonvulsant effect of two novels 4-[1-(4-fluorobenzyl)- 5-imidazolyl] dihydropyridine derivatives in mice

  2013cites this paper
• The role of α₂-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice.

  2013cites this paper
• The Role of CB1‐Receptors in the Proconvulsant Effect of Leptin on Penicillin‐Induced Epileptiform Activity in Rats

  2013cites this paper
• Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.

  2012cites this paper
• Anticonvulsant Effect of Berberis integerrima L. Root Extracts in Mice

  2012cites this paper
• L-Type Calcium Channel Mediates Anticonvulsant Effect of Cannabinoids in Acute and Chronic Murine Models of Seizure

  2011cites this paper
• DEVELOPING NEW MEDICINES FROM CANNABIS SATIVA: CHALLENGES AND PERSPECTIVES

  2011cites this paper
• Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice.

  2011cites this paper
• The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats.

  2011cites this paper
• Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.

  2010cites this paper
• Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats

  2010cites this paper
• Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

  2010cites this paper
• The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats.

  2010cites this paper
• Anticonvulsant Effect of Citrus Bigaradia Duh. Leaves Extracts in Mice

  2009cites this paper
• Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice.

  2009cites this paper
• The effects of intracerebroventricular AM‐251, a CB1‐receptor antagonist, and ACEA, a CB1‐receptor agonist, on penicillin‐induced epileptiform activity in rats

  2009influential citation
• Methods and Applications of Epilepsy Assays

  2009cites this paper
• The Endocannabinoid System as a Therapeutic Target in Epilepsy

  2008cites this paper
• An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.

  2008cites this paper
• Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice

  2008influential citation
• Cannabinoids in health and disease

  2007cites this paper
• See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication

  year unknowncites this paper